HR
OGN icon

Howe & Rusling’s Organon & Co OGN Stock Holding History

Howe & Rusling’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-113
Closed -$3K – 803
2022
Q3 		$3K Buy
113
+17
+18% +$513 ﹤0.01% 797
2022
Q2 		$3K Hold
96
– – ﹤0.01% 803
2022
Q1 		$3K Sell
96
-51
-35% -$1.74K ﹤0.01% 796
2021
Q4 		$4K Sell
147
-16
-10% -$521 ﹤0.01% 740
2021
Q3 		$5K Sell
163
-472
-74% -$15.1K ﹤0.01% 660
2021
Q2 		$19K Buy
+635
New +$20.9K ﹤0.01% 410

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Howe & Rusling's OGN Position: Q4 2022 in Review

Howe & Rusling sold out of Organon & Co (OGN) in Q4 2022, closing a stake of 113 shares — an estimated $3K sold.

Howe & Rusling first reported a position in OGN in Q2 2021 and held it in 6 quarters. The position peaked at $19K in Q2 2021. 821 funds tracked by Wall St. Rank hold OGN as of Q4 2022.

  • Howe & Rusling reported no remaining Organon & Co position as of Q4 2022 after selling out during the quarter.
  • Howe & Rusling sold 113 Organon & Co shares in Q4 2022, an estimated $3K.
  • Howe & Rusling first reported a position in Organon & Co in Q2 2021 and held it in 6 quarters.
  • Howe & Rusling's Organon & Co position peaked at $19K in Q2 2021.
  • 821 funds tracked by Wall St. Rank held Organon & Co as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.